Basal omega-3 fatty acid status affects fatty acid and oxylipin responses to high-dose n3-HUFA in healthy volunteers

被引:92
作者
Keenan, Alison H. [1 ]
Pedersen, Theresa L. [2 ]
Fillaus, Kristi [3 ]
Larson, Mark K. [4 ]
Shearer, Gregory C. [3 ,5 ]
Newman, John W. [1 ,2 ]
机构
[1] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA
[2] ARS, Western Human Nutr Res Ctr, Davis, CA 95616 USA
[3] Univ S Dakota, Sanford Res, Cardiovasc Hlth Res Ctr, Sioux Falls, SD 57117 USA
[4] Augustana Coll, Dept Biol, Sioux Falls, SD 57197 USA
[5] Univ S Dakota, Sanford Sch Med, Vermillion, SD 57069 USA
基金
美国食品与农业研究所;
关键词
omega-3 fatty acids; oxylipins; targeted metabolomics; baseline status; highly unsaturated fatty acid; CORONARY-HEART-DISEASE; EPOXYEICOSATRIENOIC ACIDS; OMEGA-3; INDEX; ETHYL-ESTERS; DOCOSAHEXAENOIC ACID; CARDIOVASCULAR-DISEASE; EICOSAPENTAENOIC ACID; ARACHIDONIC-ACID; RISK-FACTOR; INFLAMMATION;
D O I
10.1194/jlr.P025577
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A subject's baseline FA composition may influence the ability of dietary highly unsaturated omega-3 FAs (n3-HUFA) to change circulating profiles of esterified FAs and their oxygenated metabolites. This study evaluates the influence of basal n3-HUFA and n3-oxylipin status on the magnitude of response to n3-HUFA consumption. Blood was collected from fasting subjects (n = 30) before and after treatment (4 weeks; 11 +/- 2 mg/kg/day n3-HUFA ethyl esters). Esterified FAs were quantified in erythrocytes, platelets, and plasma by GC-MS. Esterified oxylipins were quantified in plasma by LC-MS/MS. Treatment with n3-HUFAs increased n3-HUFAs and decreased n6-HUFAs in all reservoirs and increased plasma n3-oxylipins without significantly changing n6-oxylipin concentrations. As subject basal n3-HUFAs increased, treatment-associated changes decreased, and this behavior was reflected in the percentage of 20:5n3 + 22:6n3 in red blood cell membrane FAs (i.e., the omega-3 index). To maintain an omega-3 index of 8% and thus reduce cardiovascular disease risk, our analyses suggest a maintenance dose of 7 mg/kg/day n3-HUFA ethyl esters for a 70-kg individual.(jlr) These results suggest that the basal n3 index may have clinical utility to establish efficacious therapeutic experimental feeding regimens and to evaluate the USDA Dietary Guidelines recommendations for n3-HUFA consumption.-Keenan, A. H., T. L. Pedersen, K.i Fillaus, M. K. Larson, G. C. Shearer, and J. W. Newman. Basal omega-3 fatty acid status affects fatty acid and oxylipin responses to high-dose n3-HUFA in healthy volunteers. J. Lipid Res. 2012. 53: 1662-1669.
引用
收藏
页码:1662 / 1669
页数:8
相关论文
共 52 条
  • [11] Omega-3 polyunsaturated fatty acids and human health outcomes
    Calder, Philip C.
    Yaqoob, Parveen
    [J]. BIOFACTORS, 2009, 35 (03) : 266 - 272
  • [12] Subgram daily supplementation with docosahexaenoic acid protects low-density lipoproteins from oxidation in healthy men
    Calzada, Catherine
    Colas, Romain
    Guillot, Nicolas
    Guichardant, Michel
    Laville, Martine
    Vericel, Evelyne
    Lagarde, Michel
    [J]. ATHEROSCLEROSIS, 2010, 208 (02) : 467 - 472
  • [13] THE EFFECTS OF DIETARY OMEGA-3 POLY-UNSATURATED FATTY-ACIDS ON ERYTHROCYTE-MEMBRANE PHOSPHOLIPIDS, ERYTHROCYTE DEFORMABILITY AND BLOOD-VISCOSITY IN HEALTHY-VOLUNTEERS
    CARTWRIGHT, IJ
    POCKLEY, AG
    GALLOWAY, JH
    GREAVES, M
    PRESTON, FE
    [J]. ATHEROSCLEROSIS, 1985, 55 (03) : 267 - 281
  • [14] Efficacy and tolerability of adding prescription omega-3 fatty acids 4 g/d to simvastatin 40 mg/d in hypertriglyceridemic patients: An 8-week, randomized, double-blind, placebo-controlled study
    Davidson, Michael H.
    Stein, Evan A.
    Bays, Harold E.
    Maki, Kevin C.
    Doyle, Ralph T.
    Shalwitz, Robert A.
    Ballantyne, Christie M.
    Ginsberg, Henry N.
    [J]. CLINICAL THERAPEUTICS, 2007, 29 (07) : 1354 - 1367
  • [15] n-3 fatty acids and gene expression
    Deckelbaum, Richard J.
    Worgall, Tilla S.
    Seo, Toru
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2006, 83 (06) : 1520S - 1525S
  • [16] Omega-6 fatty acids and coronary artery disease: The pros and cons
    Dubnov G.
    Berry E.M.
    [J]. Current Atherosclerosis Reports, 2004, 6 (6) : 441 - 446
  • [17] Omega-3 fatty acid supplements improve the cardiovascular risk profile of subjects with metabolic syndrome, including markers of inflammation and auto-immunity
    Ebrahimi, Mahmoud
    Ghayour-Mobarhan, Majid
    Rezaiean, Samaneh
    Hoseini, Maryam
    Parizade, Seyyed Mohamad Reza
    Farhoudi, Fatemeh
    Hosseininezhad, Syyed Javad
    Tavallaei, Shima
    Vejdani, Amirhosein
    Azimi-Nezhad, Mohsen
    Shakeri, Mohamad Taghi
    Rad, Mina Akbari
    Mobarra, Naser
    Kazemi-Bajestani, Seyyed Mohammad Reza
    Ferns, Gordon A. A.
    [J]. ACTA CARDIOLOGICA, 2009, 64 (03) : 321 - 327
  • [18] ELBOUSTANI S, 1987, LIPIDS, V22, P711, DOI 10.1007/BF02533970
  • [19] Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators:: protectin D1 and 17S-hydroxy-DHA
    Gonzalez-Periz, Ana
    Planaguma, Anna
    Gronert, Karsten
    Miquel, Rosa
    Lopez-Parra, Marta
    Titos, Esther
    Horrillo, Raquel
    Ferre, Natalia
    Deulofeu, Ramon
    Arroyo, Vicente
    Rodes, Juan
    Claria, Joan
    [J]. FASEB JOURNAL, 2006, 20 (14) : 2537 - +
  • [20] GOODNIGHT SH, 1981, BLOOD, V58, P880